Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Evaxion Biotech A/S ADR (NQ: EVAX )

1.412 -0.078 (-5.22%)
Streaming Delayed Price Updated: 9:52 AM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Evaxion Biotech A/S ADR

< Previous 1 2 3 4 5 6 7 Next >
Evaxion announces business update and third quarter 2024 financial results
From Evaxion Biotech
Via GlobeNewswire
Evaxion Biotech Partners With Merck To Expand Vaccine Development
Evaxion Biotech enters an expanded collaboration with Merck, granting an option to license preclinical vaccine candidates. The deal includes $3.2 million upfront and potential earnings up to $592... 
Via Benzinga
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Recap: Evaxion Biotech Q4 Earnings
Via Benzinga
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
EVAX Stock Earnings: Evaxion Biotech Beats EPS, Beats Revenue for Q2 2024
EVAX stock results show that Evaxion Biotech beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Evaxion Announces Business Update and Second Quarter 2024 Financial Results
From Evaxion Biotech
Via GlobeNewswire
iAccess Alpha's Buyside Best Ideas Virtual Summer Conference June 25-26, 2024
Via ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
EVAX Stock Earnings: Evaxion Biotech Beats EPS, Beats Revenue for Q1 2024
EVAX stock results show that Evaxion Biotech beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Evaxion Announces Business Update and First Quarter 2024 Financial Results
From Evaxion Biotech
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus Infection
From Evaxion Biotech
Via GlobeNewswire
EVAX Stock Earnings: Evaxion Biotech Meets EPS for Q4 2023
EVAX stock results show that Evaxion Biotech met analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Evaxion Announces Business Update and Full Year 2023 Financial Results
From Evaxion Biotech
Via GlobeNewswire
Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ Platform
From Evaxion Biotech
Via GlobeNewswire
Evaxion to Host R&D Day on March 19, 2024, Highlighting its Latest Technology Innovations
From Evaxion Biotech
Via GlobeNewswire
Evaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSD
From Evaxion Biotech
Via GlobeNewswire
Evaxion Regains Compliance with Nasdaq Minimum Bid Price Requirement
From Evaxion Biotech
Via GlobeNewswire
Evaxion Announces Closing of $15 Million Public Offering
From Evaxion Biotech
Via GlobeNewswire
Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results. 
Via Benzinga
Evaxion Biotech Announces Pricing of $15 Million Public Offering
From Evaxion Biotech
Via GlobeNewswire
Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results. AMD reported fourth-quarter non-GAAP earnings per share of 77 cents per share on... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Dow Edges Lower; US Composite PMI Rises In January
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning lower on Wednesday. The Dow traded down 0.05% to 37,886.62 while the NASDAQ rose 0.59% to 15,517.32. The S&P 500... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Cancer Therapy Focused Evaxion Biotech Stock Trading Higher Today?
Evaxion Biotech revolutionizes cancer vaccine development, targeting AI-identified ERVs. Preclinical activities underway; Proof-of-Concept data expected by 2H 2024. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.